Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,578 | 23,867 | 14,716 | 11,433 | 8,906 |
| Marketable Securities | N/A | N/A | 3,593 | 5,933 | 550 |
| TOTAL | $24,996 | $24,420 | $19,579 | $17,656 | $9,799 |
| Non-Current Assets | |||||
| PPE Net | 4 | 10 | 20 | 25 | 38 |
| Other Non-Current Assets | 104 | 81 | 176 | 63 | 65 |
| TOTAL | $108 | $91 | $196 | $88 | $103 |
| Total Assets | $25,104 | $24,511 | $19,775 | $17,744 | $9,902 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 817 | 1,270 | 1,304 | 1,115 | 916 |
| Accrued Expenses | 2,621 | 919 | 1,232 | 1,516 | 2,362 |
| Other current liabilities | 422 | 224 | 316 | 350 | 222 |
| TOTAL | $3,860 | $2,419 | $2,862 | $2,994 | $3,513 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $6 | $16 | $29 |
| Total Liabilities | $3,860 | $2,419 | $2,868 | $3,010 | $3,542 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,969 | 62,704 | 49,763 | 48,473 | 34,732 |
| Common Shares | 72 | 62 | 50 | 40 | 26 |
| Retained earnings | -176,204 | -150,238 | -130,072 | -110,011 | -98,438 |
| Other shareholders' equity | -97 | -101 | -6,102 | -117 | -353 |
| TOTAL | $21,244 | $22,092 | $16,907 | $14,734 | $6,360 |
| Total Liabilities And Equity | $25,104 | $24,511 | $19,775 | $17,744 | $9,902 |